person · Reporting owner
BERNSTEIN JEFFREY DANIEL
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Privia Health Group, Inc.PRVA · Entity 1532 | Director | May 08, 2023 | May 10, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Privia Health Group, Inc.
Report date May 08, 2023 · Filed May 10, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnotes | 110,337 |
Reported balance
After 2023-05-08 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2023-05-08 · Sale · Disposed 24,819,473 · Balance 110,337 F1: Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), Broad Street Principal Investments, L.L.C., MBD 2013 Holdings L.P. and Bridge Street 2013 Holdings L.P. offered and sold an aggregate 24,819,473 shares of Common Stock as set forth in the final prospectus filed by the Issuer on May 5, 2023, which offering was consummated on May 8, 2023 (the "Offering"). The amount above represents the $22.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.385 per share of Common Stock. F2: The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), Broad Street Principal Investments, L.L.C., MBD 2013 Holdings L.P. and Bridge Street 2013 Holdings L.P. offered and sold an aggregate 24,819,473 shares of Common Stock as set forth in the final prospectus filed by the Issuer on May 5, 2023, which offering was consummated on May 8, 2023 (the "Offering"). The amount above represents the $22.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.385 per share of Common Stock.
F2: The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2023 Filed May 10, 2023 20:37 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock | 24,819,473 | $21.62 | $536,472,908.90 |
DisclosureSEC source: 0001209191-23-028495 · doc4.xml · nonDerivative · entry 1 BERNSTEIN JEFFREY DANIEL · CIK 0001859499 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 110,337 F1 · price: Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), Broad Street Principal Investments, L.L.C., MBD 2013 Holdings L.P. and Bridge Street 2013 Holdings L.P. offered and sold an aggregate 24,819,473 shares of Common Stock as set forth in the final prospectus filed by the Issuer on May 5, 2023, which offering was consummated on May 8, 2023 (the "Offering"). The amount above represents the $22.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.385 per share of Common Stock. F1 · ownership.direct: Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), Broad Street Principal Investments, L.L.C., MBD 2013 Holdings L.P. and Bridge Street 2013 Holdings L.P. offered and sold an aggregate 24,819,473 shares of Common Stock as set forth in the final prospectus filed by the Issuer on May 5, 2023, which offering was consummated on May 8, 2023 (the "Offering"). The amount above represents the $22.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.385 per share of Common Stock. F2 · ownership.direct: The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 23:56 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock | 3,186,888 | $22.56 | $71,896,193.28 |
DisclosureSEC source: 0000895345-22-000790 · form4.xml · nonDerivative · entry 1 BERNSTEIN JEFFREY DANIEL · CIK 0001859499 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 24,826,071 F1 · ownership.direct: The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any. F2 · ownership.direct: Pursuant to an underwriting agreement, dated November 16, 2022 (the "Underwriting Agreement"), the GS Funds (as defined below) offered and sold an aggregate 3,186,888 shares of Common Stock as set forth in the final prospectus filed by the Issuer on November 18, 2022, which offering was consummated on November 21, 2022 (the "Offering"). The amount above represents the $23.50 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.94 per share of Common Stock. F3 · ownership.direct: As of November 21, 2022, as a result of the Offering, GS Group and Goldman Sachs may be deemed to beneficially own indirectly 24,826,071 shares of Common Stock by reason of Common Stock held by certain investment entities (the "GS Funds") of which Goldman Sachs and GS Group are the general partner, managing limited partner, managing general partner, managing partner, managing member or member. Read SEC document |
| November 23, 2021 Filed Nov 25, 2021 02:07 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock | 2,505,732 | $27.70 | $69,396,247.74 |
DisclosureSEC source: 0000895345-21-000988 · form4.xml · nonDerivative · entry 1 BERNSTEIN JEFFREY DANIEL · CIK 0001859499 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 28,676,936 F1 · ownership.direct: The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any. F2 · ownership.direct: On May 11, 2021, Brighton Health Group Holdings, LLC made a pro rata distribution of 79,178,464 shares of common stock, par value $0.01 per share (the "Common Stock") of the Issuer to its members, including an aggregate 30,512,093 shares of Common Stock to the GS Funds (as defined below). F3 · ownership.direct: Pursuant to an underwriting agreement, dated November 18, 2021 (the "Underwriting Agreement"), the GS Funds (as defined below) offered and sold an aggregate 2,505,732 shares of Common Stock as set forth in the final prospectus filed by the Issuer on November 22, 2021, which offering was consummated on November 23, 2021 (the "Offering"). The amount above represents the $29.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $1.305 per share of Common Stock. F4 · ownership.direct: As of November 22, 2021, as a result of the Offering, GS Group and Goldman Sachs may be deemed to beneficially own indirectly 28,006,361 shares of Common Stock by reason of Common Stock held by certain investment entities (the "GS Funds") of which Goldman Sachs and GS Group are the general partner, managing limited partner, managing general partner, managing partner, managing member or member. Read SEC document |
| May 03, 2021 Filed May 5, 2021 22:19 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock | 16,700,000 | $21.62 | $361,054,000.00 |
DisclosureSEC source: 0000895345-21-000494 · form4.xml · nonDerivative · entry 1 BERNSTEIN JEFFREY DANIEL · CIK 0001859499 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 79,178,470 F2 · price: Pursuant to an underwriting agreement, dated April 28, 2021 (the "Underwriting Agreement"), and in connection with the initial public offering of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. (the "Company") by the Company, Brighton Health Group Holdings, LLC ("BHG"), the Company's parent holding company, sold 16,700,000 shares of Common Stock pursuant to the final prospectus filed by the Company on April 30, 2021, which offering was consummated on May 3, 2021 (the "Initial Public Offering"). The amount above represents the $23.00 public offering price per share of Common Stock in the Initial Public Offering less the underwriting discount of $1.38 per share of Common Stock. The membership interests in BHG are held by a private investor group, which includes the GS Funds (as defined below). F1 · ownership.direct: The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any. F2 · ownership.direct: Pursuant to an underwriting agreement, dated April 28, 2021 (the "Underwriting Agreement"), and in connection with the initial public offering of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. (the "Company") by the Company, Brighton Health Group Holdings, LLC ("BHG"), the Company's parent holding company, sold 16,700,000 shares of Common Stock pursuant to the final prospectus filed by the Company on April 30, 2021, which offering was consummated on May 3, 2021 (the "Initial Public Offering"). The amount above represents the $23.00 public offering price per share of Common Stock in the Initial Public Offering less the underwriting discount of $1.38 per share of Common Stock. The membership interests in BHG are held by a private investor group, which includes the GS Funds (as defined below). F3 · ownership.direct: As of May 3, 2021, as a result of the Initial Public Offering, GS Group and Goldman Sachs may be deemed to beneficially own indirectly 79,178,470 shares of Common Stock by reason of the membership interests in BHG held by certain investment entities (the "GS Funds") of which Goldman Sachs and GS Group are the general partner, managing limited partner, managing general partner, managing partner, managing member or member. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.